CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Istari Oncology, Inc.

For profitWebsite ↗

Also known as: Istari Oncology, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Dec 31, 2023

Timeline

2010s

Jun 1, 2014
Istari Oncology, Inc.— Founded

Drugs by trial phase (7 distinct, 10 trials)

Phase 2 (5 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (12)

NCT04599647Lead sponsorN/A—
NCT06177964CollaboratorPhase 2Dec 31, 2023
NCT04690699Lead sponsorPhase 1/Phase 2Aug 1, 2021
NCT04577807Lead sponsorPhase 2Nov 17, 2020
NCT04479241Lead sponsorPhase 2Oct 21, 2020
NCT04160494CollaboratorPhase 1Dec 31, 2019
NCT04125719CollaboratorPhase 1Dec 1, 2019
NCT03973879Study directorPhase 1/Phase 2Aug 1, 2019
NCT03973879CollaboratorPhase 1/Phase 2Aug 1, 2019
NCT03712358Lead sponsorPhase 1Nov 26, 2018
NCT03564782Lead sponsorEarly Phase 1Sep 24, 2018
NCT03564782Study directorEarly Phase 1Sep 24, 2018

Details

Founded: Durham, NC, US Jun 1, 2014
Last known activity: Dec 31, 2023